β₂-adrenoceptor agonists: current and future directionCAZZOLA, Mario; CALZETTA, Luigino; MATERA, Maria Gabriella et al.British journal of pharmacology. 2011, Vol 163, Num 1, pp 4-17, issn 0007-1188, 14 p.Article

Beyond the dogma : novel β₂-adrenoceptor signalling in the airwaysGIEMBYCZ, M. A; NEWTON, R.The European respiratory journal. 2006, Vol 27, Num 6, pp 1286-1306, issn 0903-1936, 21 p.Article

Agonist-specific patterns of β₂-adrenoceptor responses in human airway cells during prolonged exposureDÜRINGER, Caroline; GRUNDSTRÖM, Gunilla; SKÖLD, Carl Magnus et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 169-179, issn 0007-1188, 11 p.Article

Effect of indacaterol, a novel long-acting β₂-agonist, on isolated human bronchiNALINE, E; TRIFILIEFF, A; FAIRHURST, R. A et al.The European respiratory journal. 2007, Vol 29, Num 3, pp 575-581, issn 0903-1936, 7 p.Article

On the mechanism of the persistent action of salmeterol: what is the current position?COLEMAN, R. A.British journal of pharmacology. 2009, Vol 158, Num 1, pp 180-182, issn 0007-1188, 3 p.Article

Anti-bronchoconstrictor activities and side effect potential of inhaled formoterol and (S, R)-epiformoterol in the rhesus monkeyFOZARD, John R; BUESCHER, Heinz.Drug development research. 2002, Vol 57, Num 1, pp 1-5, issn 0272-4391, 5 p.Article

Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammationWYSS, D; BONNEAU, O; TRIFILIEFF, A et al.British journal of pharmacology. 2007, Vol 152, Num 1, pp 83-90, issn 0007-1188, 8 p.Article

A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of β₂-adrenoceptor agonists as inhaled long-acting bronchodilatorsBEATTIE, David; BRADLEY, Michelle; LEWIS, Christine et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 17, pp 5302-5307, issn 0960-894X, 6 p.Article

Effects of salbutamol and caffeine ingestion on exercise metabolism and performanceCOLLOMP, K; CANDAU, R; MILLET, G et al.International journal of sports medicine. 2002, Vol 23, Num 8, pp 549-554, issn 0172-4622, 6 p.Article

Rapid and sensitive assay for trantinterol, a novel β₂-adrenoceptor agonist, in human plasma using liquid chromatography-tandem mass spectrometryYANTONG SUN; MINGYUAN LIU; JIWEN ZHANG et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 4, pp 1056-1059, issn 0731-7085, 4 p.Article

Acute myocardial infarction associated with albuterolFISHER, Alexander A; DAVIS, Michael W; MCGILL, Darryl A et al.The Annals of pharmacotherapy. 2004, Vol 38, Num 12, pp 2045-2049, issn 1060-0280, 5 p.Article

β₂-Adrenoceptor Agonists Enhance Cytokine-Induced Release of Thymic Stromal Lymphopoietin by Lung Tissue CellsFUTAMURA, Kyoko; ORIHARA, Kanami; HASHIMOTO, Noriko et al.International archives of allergy and immunology. 2010, Vol 152, Num 4, pp 353-361, issn 1018-2438, 9 p.Article

An investigation into the structure―activity relationships associated with the systematic modification of the β₂-adrenoceptor agonist indacaterolBEATTIE, David; BEER, David; ROSETHORNE, Elizabeth M et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 19, pp 6280-6285, issn 0960-894X, 6 p.Article

Design, synthesis and in vitro evaluation of (R)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenyl hydrogen phenylboronate: A novel salbutamol derivative with high intrinsic efficacy on the β₂ adrenoceptorSORIANO-URSUA, Marvin A; CORREA-BASURTO, José; VALENCIA-HERNANDEZ, Ignacio et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 19, pp 5623-5629, issn 0960-894X, 7 p.Article

The effect of β₂-adrenoceptor agonists on phospholipase C (betal) signalling in human airway smooth muscle cellsSAYERS, Ian; SWAN, Caroline; HALL, Ian P et al.European journal of pharmacology. 2006, Vol 531, Num 1-3, pp 9-12, issn 0014-2999, 4 p.Article

Pharmacogenetic characterization of indacaterol, a novel β₂-adrenoceptor agonistSAYERS, I; HAWLEY, J; STEWART, C. E et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 277-286, issn 0007-1188, 10 p.Article

Cells, mediators and Toll-like receptors in COPDSARIR, Hadi; HENRICKS, Paul A. J; VAN HOUWELINGEN, Anneke H et al.European journal of pharmacology. 2008, Vol 585, Num 2-3, pp 346-353, issn 0014-2999, 8 p.Article

The arginine-16 β₂-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterolLEE, Daniel K. C; CURRIE, Graeme P; HALL, Ian P et al.British journal of clinical pharmacology. 2004, Vol 57, Num 1, pp 68-75, issn 0306-5251, 8 p.Article

A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmaticsCURRIE, Graeme P; LEE, Daniel K. C; DEMPSEY, Owen J et al.British journal of clinical pharmacology. 2003, Vol 55, Num 6, pp 609-615, issn 0306-5251, 7 p.Article

A multivalent approach to the discovery of long-acting β₂-adrenoceptor agonists for the treatment of asthma and COPDJACOBSEN, John R; SEOK KI CHOI; COMBS, Jesse et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 2, pp 1213-1218, issn 0960-894X, 6 p.Article

Enhancement of inflammatory mediator release by β₂-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid actionHOLDEN, N. S; RIDER, C. F; BELL, M. J et al.British journal of pharmacology. 2010, Vol 160, Num 2, pp 410-420, issn 0007-1188, 11 p.Article

β₂-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathwayFREUND-MICHEL, V. C; BIRRELL, M. A; GIEMBYCZ, M. A et al.The European respiratory journal. 2010, Vol 35, Num 3, pp 647-654, issn 0903-1936, 8 p.Article

Dark cell change of the cerebellar Purkinje cells induced by terbutaline under transient disruption of the blood―brain barrier in adult rats: morphological evaluationYAMADA, Naoaki; SASAKI, Satoshi; ISHII, Hiroyuki et al.JAT. Journal of applied toxicology. 2012, Vol 32, Num 9-10, pp 790-795, issn 0260-437X, 6 p.Article

Can β₂-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?ZHANG, Wen-Hui; YONG ZHANG; CUI, Yong-Yao et al.Fundamental & clinical pharmacology. 2012, Vol 26, Num 1, pp 118-134, issn 0767-3981, 17 p.Article

Harnessing the Clinical Efficacy of Phosphodiesterase 4 Inhibitors in Inflammatory Lung Diseases: Dual-Selective Phosphodiesterase Inhibitors and Novel Combination TherapiesGIEMBYCZ, Mark A; NEWTON, Robert.Handbook of experimental pharmacology. 2011, Vol 204, pp 415-446, issn 0171-2004, 32 p.Article